VIM and breast cancer: However, treatment with JNKi caused a significant reduction in both mammary tumor growth and pulmonary metastasis in MDA231‐LM2 and SUM159‐LM1 xenograft models, as assessed by tumor volume and number of human vimentin‐positive foci in lung sections (Fig 1H–J).